• Clinical Evidence

Proof in the (Sugar-Free) Pudding: Implementing Computerized Insulin Drip Management

Setting: 114-bed not-for-profit community hospital affiliated with a major academic medical center

Objective

This retrospective case study examines clinical outcomes following implementation of a computerized glucose management system (EndoTool) in the intensive care unit.

Setting

114-bed not-for-profit community hospital affiliated with a major academic medical center.

Results

  • Incidence of hypoglycemia <40 mg/dL was 0.0% of patient days with EndoTool.
  • Incidence of hypoglycemia <70 mg/dL was 0.6% of patient days with EndoTool.
  • 96.1% of blood glucose checks were classified as timely (i.e., within a 30-minute window) with EndoTool.

Conclusions

A computerized glucose management system (EndoTool) is associated with a very low rate of hypoglycemia and nearly full compliance with timely blood glucose checks for patients on an insulin drip; also, built-in analytics allow for insights otherwise difficult to obtain.
Objective

This retrospective case study examines clinical outcomes following implementation of a computerized glucose management system (EndoTool) in the intensive care unit.

Setting

114-bed not-for-profit community hospital affiliated with a major academic medical center.

Results
  • Incidence of hypoglycemia <40 mg/dL was 0.0% of patient days with EndoTool.
  • Incidence of hypoglycemia <70 mg/dL was 0.6% of patient days with EndoTool.
  • 96.1% of blood glucose checks were classified as timely (i.e., within a 30-minute window) with EndoTool.
Conclusions

A computerized glucose management system (EndoTool) is associated with a very low rate of hypoglycemia and nearly full compliance with timely blood glucose checks for patients on an insulin drip; also, built-in analytics allow for insights otherwise difficult to obtain.

References

Authors

Karen Mahnke, MSN, RN, NEA-BC; Anthony Pick, MD; Laura Meller, MS, APRN, NE-BC; Samy Gonstal, BSN, CCRN; Chris Somberg, MS, APRN-CNS, ACNS-BC, NE-BC.

Source

Presented at Vizient Connections Summit.

Year

2022

Quick navigation
Objective
Setting
Results
Conclusions
References
Objective

This retrospective case study examines clinical outcomes following implementation of a computerized glucose management system (EndoTool) in the intensive care unit.

Setting

114-bed not-for-profit community hospital affiliated with a major academic medical center.

Results
  • Incidence of hypoglycemia <40 mg/dL was 0.0% of patient days with EndoTool.
  • Incidence of hypoglycemia <70 mg/dL was 0.6% of patient days with EndoTool.
  • 96.1% of blood glucose checks were classified as timely (i.e., within a 30-minute window) with EndoTool.
Conclusions

A computerized glucose management system (EndoTool) is associated with a very low rate of hypoglycemia and nearly full compliance with timely blood glucose checks for patients on an insulin drip; also, built-in analytics allow for insights otherwise difficult to obtain.

References

Authors

Karen Mahnke, MSN, RN, NEA-BC; Anthony Pick, MD; Laura Meller, MS, APRN, NE-BC; Samy Gonstal, BSN, CCRN; Chris Somberg, MS, APRN-CNS, ACNS-BC, NE-BC.

Source

Presented at Vizient Connections Summit.

Year

2022

Short and Sweet Headlines are Best!

Related posts

Image
  • Clinical Evidence

Near Elimination of Severe Hypoglycemia with EndoTool IV Across a 19-Hospital Health System

Near Elimination of Severe Hypoglycemia with EndoTool IV Across a 19-Hospital Health System

To evaluate the impact of EndoTool IV insulin dosing software on reducing severe hypoglycemia (SH) (blood glucose < 40 mg/dL) across 19-hospitals at a prominent health system, including outcomes in patients with renal insufficiency.
Image
  • Clinical Evidence

Temple Health Achieves Zero Severe Hypoglycemia in Renally Impaired Patients with EndoTool SubQ

Temple Health Achieves Zero Severe Hypoglycemia in Renally Impaired Patients with EndoTool SubQ

To evaluate the safety and efficacy of the EndoTool SubQ (ETSQ) insulin dosing application for subcutaneous (SQ) insulin administration in hospitalized patients, and to compare clinical outcomes against those treated using a standard insulin order set. The analysis also examined performance in high-risk patients with advanced renal impairment.
Image
  • Clinical Evidence

Improving Inpatient Glycemic Safety at Temple Health with EndoTool SubQ

Improving Inpatient Glycemic Safety at Temple Health with EndoTool SubQ

Temple Health, a 3-hospital academic system was experiencing high rates of hypoglycemia due to reliance on sliding scale insulin (SSI). To improve safety and align with ADA guidelines, the hospital implemented EndoTool SubQ, a patient-specific insulin dosing software the supports four dosing protocols, including basal-bolus-correction (BBC).
Get in Touch

Ready to get started?

Fill in your details and one of our friendly team members will be in touch to show you how easily EndoTool can support your hospital.

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Name*
By submitting this form, you consent to the processing of your personal information, including sensitive personal information you provide, in accordance with the Monarch Medical Technologies Privacy Notice.